Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:32 pm Purchase |
2024-12-31 | 13G | InspireMD, Inc. NSPR |
Nantahala Capital Management, LLC | 2,709,118 9.990% |
101,234 (+3.88%) |
Filing History |
| 2025-02-07 11:24 am Purchase |
2024-12-31 | 13G | InspireMD, Inc. NSPR |
Rosalind Advisors, Inc. | 9,933,964 9.900% |
2,495,783 (+33.55%) |
Filing History |
| 2024-12-04 4:31 pm Purchase |
2024-11-27 | 13G | InspireMD, Inc. NSPR |
Nantahala Capital Partners Limited Partnership | 1,411,636 5.220% |
1,411,636 (New Position) |
Filing History |
| 2024-11-14 6:35 pm Unchanged |
2024-09-30 | 13G | InspireMD, Inc. NSPR |
ORBIMED ADVISORS LLC | 2,133,405 8.300% |
0 (Unchanged) |
Filing History |
| 2024-11-14 4:53 pm Purchase |
2024-09-30 | 13G | InspireMD, Inc. NSPR |
Nantahala Capital Management, LLC | 2,607,884 9.990% |
445,492 (+20.60%) |
Filing History |
| 2024-10-28 4:02 pm Unchanged |
2024-09-30 | 13G | InspireMD, Inc. NSPR |
Rosalind Advisors, Inc. | 7,438,181 9.800% |
0 (Unchanged) |
Filing History |
| 2024-07-11 5:48 pm Sale |
2024-06-28 | 13G | InspireMD, Inc. NSPR |
Rosalind Advisors, Inc. | 7,438,181 9.900% |
-21,747 (-0.29%) |
Filing History |
| 2024-05-17 12:58 pm Sale |
2024-04-24 | 13G | InspireMD, Inc. NSPR |
Rosalind Advisors, Inc. | 7,459,928 9.900% |
-1,528,390 (-17.00%) |
Filing History |
| 2024-04-25 7:30 pm Unchanged |
2024-03-31 | 13G | InspireMD, Inc. NSPR |
Rosalind Advisors, Inc. | 8,988,318 9.900% |
0 (Unchanged) |
Filing History |
| 2024-02-14 9:33 pm Unchanged |
2023-12-31 | 13G | InspireMD, Inc. NSPR |
Rosalind Advisors, Inc. | 8,988,318 9.900% |
0 (Unchanged) |
Filing History |
| 2024-02-14 7:41 pm Purchase |
2023-12-31 | 13G | InspireMD, Inc. NSPR |
ORBIMED ADVISORS LLC | 2,133,405 9.900% |
2,133,405 (New Position) |
Filing History |
| 2024-02-14 4:51 pm Purchase |
2023-12-31 | 13G | InspireMD, Inc. NSPR |
Nantahala Capital Management, LLC | 2,162,392 9.900% |
2,162,392 (New Position) |
Filing History |
| 2023-06-16 4:15 pm Purchase |
2023-06-08 | 13D | InspireMD, Inc. NSPR |
Shore Craig | 1,700,159 8.010% |
1,700,159 (New Position) |
Filing History |
| 2023-06-07 5:33 pm Purchase |
2023-06-01 | 13G | InspireMD, Inc. NSPR |
Rosalind Advisors, Inc. | 8,988,318 9.900% |
8,988,318 (New Position) |
Filing History |
| 2023-05-24 4:31 pm Purchase |
2023-05-16 | 13G | InspireMD, Inc. NSPR |
Soleus Private Equity Fund III L.P. | 2,199,118 9.900% |
2,199,118 (New Position) |
Filing History |
| 2023-05-22 4:15 pm Purchase |
2023-05-12 | 13G | InspireMD, Inc. NSPR |
Marshall Wace North America L.P. | 1,860,405 9.900% |
1,860,405 (New Position) |
Filing History |
| 2022-02-11 5:04 pm Purchase |
2021-12-31 | 13G | InspireMD, Inc. NSPR |
Lind Global Macro Fund LP | 177,333 2.100% |
177,333 (New Position) |
Filing History |
| 2021-02-09 5:00 pm Sale |
2020-12-31 | 13G | InspireMD, Inc. NSPR |
Lind Global Macro Fund LP | 137,011 5.300% |
-125,868 (-47.88%) |
Filing History |
| 2021-01-29 06:58 am Purchase |
2020-12-31 | 13G | InspireMD, Inc. NSPR |
Mitchell P. Kopin | 96,511 3.800% |
70,070 (+265.00%) |
Filing History |
| 2021-01-08 09:37 am Purchase |
2020-12-31 | 13G | InspireMD, Inc. NSPR |
SABBY MANAGEMENT LLC | 122,936 11.000% |
98,741 (+408.11%) |
Filing History |